Hormone study aims to unlock Prader-Willi feeding mystery

NCT ID NCT02529085

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at how appetite-regulating hormones change in infants with Prader-Willi syndrome during the first four years of life. Researchers collected blood samples from 215 infants to understand why they switch from poor feeding to severe overeating and obesity. The goal is to identify the underlying causes and pave the way for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help explain why children with Prader-Willi syndrome go from poor feeding to severe overeating, pointing toward future treatments.
What could go wrong
This is an observational study, not a treatment trial. It may not directly lead to therapies, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Endocrinology / University Children's Hospital

    Essen, Germany

  • Department of Pediatrics / Division of Endocrinology

    Toulouse, Haute-Garonne, 31000, France

  • Department of Pediatrics / Division of Endocrinology / Erasmus University Medical Center / Sophia Children's Hospital Rotterdam

    Rotterdam, 3015 GJ, Netherlands

  • Karolinska University Hospital

    Stockholm, Sweden

  • Metabolic & Molecular Imaging Group / MRC Clinical Sciences Centre / Imperial College London / Hammersmith Hospital

    London, W12 0NN, United Kingdom

  • Unité d'Endocrinologie Pédiatrique / Université Catholique de Louvain

    Brussels, 1200, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.